Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

14.65 +2.30 (+18.62%)

Delayed Quote Updated: 11:52 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data

September 16, 2026

From Ginkgo Bioworks

Via Business Wire

Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines

September 10, 2026

From Ginkgo Bioworks

Via Business Wire

Ginkgo Bioworks Q2 Earnings Call Highlights ↗

August 08, 2026

Ginkgo Bioworks (NYSE:DNA) reported second-quarter 2026 revenue of $20 million, down 48% from the year-earlier period, as the company continued to shift its focus toward autonomous laboratory systems,...

Via MarketBeat

Topics Earnings

Ginkgo Bioworks Holdings (NYSE:DNA) tumbles 15% in after-hours trading after Q1 revenue and earnings miss analyst estimates ↗

May 07, 2026

Via Chartmill

Topics Earnings

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Earnings Scheduled For February 25, 2025 ↗

February 25, 2025

Via Benzinga

Palantir's Bold Biosecurity Opportunity Could Be Bigger Than Investors Think ↗

June 28, 2026

A new biosecurity theme is emerging, and Palantir is leveraging it as an opportunity. Here's why that divide could matter for investors.

Via The Motley Fool

Ginkgo Bioworks Q1 Earnings Call Highlights ↗

May 09, 2026

Ginkgo Bioworks (NYSE:DNA) said it is sharpening its 2026 focus on autonomous laboratories after completing the divestiture of its biosecurity business and reporting lower year-over-year cash burn in...

Via MarketBeat

Topics Artificial Intelligence Earnings

Ginkgo Bioworks (DNA) Q1 2026 Earnings Transcript ↗

May 08, 2026

Ginkgo Bioworks (DNA) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics Artificial Intelligence

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

February 27, 2026

Via Chartmill

Which stocks are moving on Friday? ↗

February 27, 2026

Via Chartmill

What's going on in today's pre-market session ↗

February 27, 2026

Via Chartmill

Wondering what's happening in today's after-hours session? ↗

February 26, 2026

Via Chartmill

Moss, Microbes, and the Martian Dream: How Tiny Organisms Are Paving the Way for Off-World Colonies

November 24, 2025

The ambitious dream of humanity establishing permanent settlements beyond Earth is taking a significant leap forward, not through advanced robotics or colossal spacecraft, but with the humble power of...

Via TokenRing AI

Topics Artificial Intelligence Economy

Ginkgo Bioworks Stock Plummets Following Q3 Estimates Miss, Reaffirms FY2025 Outlook Below Consensus ↗

November 07, 2025

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are trading lower on Friday. The company released its third-quarter financial results.

Via Benzinga

Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday ↗

October 08, 2025

Via Benzinga

AI Unlocks Secrets of Intrinsically Disordered Proteins: A Paradigm Shift in Biomedical Design

October 06, 2025

A groundbreaking advancement in artificial intelligence has opened new frontiers in understanding and designing intrinsically disordered proteins (IDPs), a class of biomolecules previously considered...

Via TokenRing AI

Topics Artificial Intelligence Derivatives

Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium

September 04, 2025

From Ginkgo Bioworks

Via Business Wire

5 Healthcare Stocks On Fire This Week ↗

August 21, 2025

Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech & pharma.

Via Benzinga

Ginkgo Bioworks Holdings Inc (NYSE:DNA) Fits the Minervini Trend Template with Strong Technicals and High-Growth Momentum ↗

August 01, 2025

Ginkgo Bioworks (DNA) meets Minervini Trend Template criteria with strong technicals, earnings growth, and momentum, making it a high-growth stock to watch.

Via Chartmill

Hewlett Packard Enterprise, Magnite, GMS And Other Big Stocks Moving Higher On Monday ↗

June 30, 2025

Via Benzinga

Twist Bioscience and Ginkgo Bioworks Revise Collaboration

May 08, 2025

From Twist Bioscience Corporation

Via Business Wire

Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing ↗

April 14, 2025

FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.

Via Benzinga

Topics Animal Testing

Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday ↗

April 11, 2025

Via Benzinga

Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

February 26, 2025

Via Benzinga

US Stocks Likely To Open Higher Ahead Of Nvidia Earnings: S&P 500's Four-Day Fall Was A 'Non-Event,' Says Expert ↗

February 26, 2025

U.S. stock futures rose on Wednesday following two consecutive days of mixed close this week. All futures advanced in premarket trading.

Via Benzinga

Topics Stocks

Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗

February 26, 2025

Via Benzinga

Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket ↗

February 06, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.